Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aflac Inc. (AFL:NYSE), powered by AI.
Aflac Inc. is currently trading at $117.41. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Aflac Inc. on Alpha Lenz.
Aflac Inc.'s P/E ratio is 17.2.
“Aflac Inc. trades at a P/E of 17.2 (fair value) with solid ROE of 13.1%.”
Ask for details →Aflac Inc. is a leading provider of life and health insurance, offering a comprehensive portfolio of products primarily in Japan and the United States. The company’s core business centers on supplemental health and life insurance policies that cover a range of needs, including cancer, medical indemnity, accident, disability, and long-term care. Notably, Aflac is recognized for its innovative cancer insurance products and broad array of living benefit plans, which have established it as a significant player in the personal insurance market. Aflac’s operations are divided by geography, with approximately half of its revenue generated in Japan and a substantial portion from the U.S.. Its customer base ranges from individuals to corporate clients, and the company’s extensive distribution network enhances its market reach. Through subsidiaries such as Aflac Asset Management LLC and Continental American Insurance Co., the firm manages investments and multi-line insurance services, further diversifying its offerings. In the broader financial market, Aflac Inc. represents stability and scale within the insurance sector, regularly featuring among the largest global insurers by market capitalization.
“Aflac Inc. trades at a P/E of 17.2 (fair value) with solid ROE of 13.1%.”
Ask for details →Aflac Inc. (ticker: AFL) is a company listed on NYSE in the Financial Services sector (Insurance - Life). It has approximately 12,694 employees. Market cap is $62.6B.
The current price is $117.41 with a P/E ratio of 17.16x and P/B of 2.12x.
ROE is 13.12%. Annual revenue is $17.4B.